The Michael Brady Lynch Firm Files Invokana Ketoacidosis Case

October 29, 2015

For Immediate Release:

The Michael Brady Lynch Firm files first Invokana case involving allegations of diabetic ketoacidosis.

The case JENNIFER ANZO, Plaintiff, v. JANSSEN RESEARCH & DEVELOPMENT, LLC; JANSSEN PHARMACEUTICALS, INC.; JOHNSON & JOHNSON, was filed in the United States District Court of the Eastern District of California. Ms. Anzo has never explained the risks. No one told her the dangers. She only used Invokana for three months before being diagnosed with a life-threatening illness– ketoacidosis. Not only was she hospitalized in the ICU from it but also is now insulin dependent after her horrifying experience with Invokana.

What is Invokana?

Johnson & Johnson’s Janssen Pharmaceuticals unit manufactures Invokana (canagliflozin), a medication to help Type 2 diabetics control their blood sugar levels. It was the first drug of its type approved by the FDA in March 2013. Now, this dangerous drug is part of a new class of diabetes treatments called SGLT2 inhibitors.

Sodium-glucose cotransporter-2 (SGLT2) inhibitors help prevent hyperglycemia (high blood sugar levels) by helping the patient’s kidneys remove excess sugar from the body through the urine. Other medications in the class include Farxiga, Glyxambi, Invokamet, Jardiance, and Xigduo. So far, Invokana is the top-grossing drug in its class.

Invokana: Diabetes Blockbuster Drug for Johnson & Johnson

In the first quarter of 2015, the drug already brought in $278 million, triple what it made last year, with sales projected to eventually exceed $1.2 billion per year. To boost sales, Janssen has heavily promoted the drug both for its approved “on-label” use but also for “off-label” uses such as weight loss.

With more people being diagnosed with Type 2 diabetes than ever before, the drug is poised to make more profits for Janssen in the future. Since the drug is well-received by commercial insurance companies and Medicare Part D, it is more likely to be covered and prescribed to a higher number of people.

Invokana Side Effects

Consumer protection group Institute for Safe Medication Practices (ISMP) linked Invokana to hundreds of severe adverse events within the first 12 months of its market release. The Invokana label does not warn patients of these dangerous side effects.

Contact us if you or a loved one has suffered any of the following:

Diabetic ketoacidosis
Kidney failure or impairment
Heart attack
Stroke

Many of these dangerous side effects manifest themselves very early after a patient begins taking Invokana. For example, many patients have suffered strokes within the first 30 days of taking the drug.

FDA Warning: Invokana Linked to Diabetic Ketoacidosis

In May 2015, the FDA issued a Safety Communication for all drugs in the SGLT2 inhibitor class regarding the risk of developing diabetic ketoacidosis. So far, the FDA said it received about 20 cases of ketoacidosis, and all patients were hospitalized for treatment. The FDA’s European counterpart, the EMA, is reporting devastating effects as well. Over 100 cases of ketoacidosis-related to SGLT2 drugs have been reported. Most patients took the drug for two weeks or less before symptoms showed up, and almost all had to be hospitalized.

The symptoms of diabetic ketoacidosis are:

Abdominal pain
Decreased alertness or confusion
Dry mouth and skin
Frequent urination
Extreme thirst that lasts a day or more
Fatigue
Flushed face
Fruity-smelling breath
Headache
Muscle stiffness or aches
Nausea and vomiting
Rapid breathing

Take Action 

If you developed ketoacidosis, you may have legal options. The Michael Brady Lynch Firm is currently accepting Invokana injury and death cases in all 50 states. If you or somebody you know was diagnosed with diabetic ketoacidosis or had any of these other side effects, you should contact our lawyers immediately. Each lawyer is skilled in drug-related injuries and will provide a free case consultation.

About the Firm

The Michael Brady Lynch Firm is a national trial firm with a focus on pharmaceutical mass tort cases involving SSRI and Anti-Seizure Medication Birth Defects including Lexapro, Zoloft, Effexor, Prozac, Celexa, Paxil, Depakote and Topamax, Xarelto bleeding injuries, Mirena IUD, Actos Bladder Cancer, Invokana ketoacidosis, Testosterone heart attack and stroke injuries and medical device cases including DePuy Hip and Trans-Vaginal Mesh cases. Contact us today if you or someone you know has experienced side effects involving any of these products.

Leave a Reply

Your email address will not be published. Required fields are marked *

Contact Us Today

Contact our lawyers directly through the email form below.
  • * Denotes a required field
  • This field is for validation purposes and should be left unchanged.